Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar

We are proud of our mission, vision, and core values, and we invite you to follow along and support us in our pursuit of improving lives through therapeutic innovation.